ANU research could lead to better treatment options for rare, deadly bacterial infection

NewsGuard 100/100 Score

New research from The Australian National University (ANU) could lead to better treatment options for a rare but very lethal type of bacterial infection.

Professor Si Ming Man and his team say their latest research focuses on the family of bacteria that causes things like gangrene, sepsis and tetanus.

While we understand a select few members of this family of bacteria, we were interested in what the others were doing to cause infection.

Thankfully, this group of bacteria is rare – less than 1,000 cases a year in the US.

But one in particular we looked at for this study, Clostridium septicum, kills four out of five people who get it within two days. It's incredibly lethal."

Professor Si Ming Man, The Australian National University

The team discovered Clostridium septicum can rapidly kill cells by releasing a toxin that acts "like a hammer" punching holes in the surface of the cell.

This sends a danger signal to the immune system, but when our body swings into action it can actually cause more harm than good.

"The intention of the immune system is good – it's trying to fight against the bacteria – but the infected cells also explode and die," Professor Man said.

"When the bacteria spreads and you have lots of dying cells all over the body that's when it can lead to sepsis and shock. That is why patients die very rapidly."

While there are currently extremely limited treatment options, it is hoped this study could help change that – leading to better outcomes for patients.

"Our research shows there might be new therapies we could develop, such as using certain drugs to neutralize the toxin," Professor Man said.

"We've also shown there are drugs in the clinical trial stage right now that could block the single immune receptor, blocking your own immune system from responding to this toxin too violently.

"Together this could be a life-saving therapy."

The bacteria can also be deadly in sheep and cows, so any new treatment or vaccination could be used to save livestock.

Source:
Journal reference:

Jing, W., et al. (2022) Clostridium septicum α-toxin activates the NLRP3 inflammasome by engaging GPI-anchored proteins. Science Immunology. doi.org/10.1126/sciimmunol.abm1803.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gut bacteria manipulation may offer a promising approach to managing inflammatory bowel disease